Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Strata Critical Medical (SRTA) Cost of Revenue (2021 - 2025)

Strata Critical Medical (SRTA) has disclosed Cost of Revenue for 5 consecutive years, with $55.1 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 75.68% to $55.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $147.3 million through Dec 2025, down 3.66% year-over-year, with the annual reading at $156.0 million for FY2025, 33.09% up from the prior year.
  • Cost of Revenue for Q4 2025 was $55.1 million at Strata Critical Medical, up from $37.7 million in the prior quarter.
  • The five-year high for Cost of Revenue was $175.0 million in Q4 2023, with the low at $1.2 million in Q3 2021.
  • Average Cost of Revenue over 5 years is $31.6 million, with a median of $30.0 million recorded in 2024.
  • The sharpest move saw Cost of Revenue surged 2861.49% in 2022, then plummeted 96.53% in 2025.
  • Over 5 years, Cost of Revenue stood at $20.7 million in 2021, then soared by 60.37% to $33.2 million in 2022, then soared by 427.84% to $175.0 million in 2023, then tumbled by 82.08% to $31.4 million in 2024, then surged by 75.68% to $55.1 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $55.1 million, $37.7 million, and $53.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.